Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 35 | 50 | 40 | 65 | 46 |
| Cost of Goods | 8 | 8 | 8 | 12 | 30 |
| Gross Profit | 27 | 42 | 32 | 53 | 16 |
| Operating Expenses | 4,524 | 3,744 | 5,774 | 14,068 | 8,203 |
| Operating Income | -4,489 | -3,694 | -5,734 | -14,003 | -8,157 |
| Interest Expense | 202 | 179 | 72 | 0 | 0 |
| Other Income | 991 | 2,037 | -11 | 1,427 | 341 |
| Pre-tax Income | -3,700 | -1,836 | -5,817 | -12,576 | -7,816 |
| Net Income Continuous | -3,700 | -1,836 | -5,817 | -12,576 | -7,816 |
| Net Income | $-3,700 | $-1,836 | $-5,817 | $-12,576 | $-7,816 |
| EPS Basic Total Ops | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| EPS Basic Continuous Ops | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| EPS Diluted Total Ops | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| EPS Diluted Continuous Ops | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.03 | -0.12 | -0.26 | -0.16 |
| EBITDA(a) | $-4,418 | $-3,436 | $-5,603 | $-13,945 | $-8,090 |